Patents by Inventor Kraig Yager

Kraig Yager has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ANTIVIRAL COMPOUNDS AND USE THEREOF
    Publication number: 20090275583
    Abstract: The invention relates to compounds, pharmaceutical compositions and methods useful for treating viral infection.
    Type: Application
    Filed: April 13, 2009
    Publication date: November 5, 2009
    Applicant: Myriad Genetics, Incorporated
    Inventors: Kraig Yager, In Chul Kim, Michael Saunders, David Gerrish, Dange Vijay Kumar, Mark B. Anderson
  • Anti-bacterial agents based upon oxoanion binding
    Publication number: 20070054883
    Abstract: Compounds of the structure I: are useful for treating bacterial growth, wherein E is selected from the group consisting of B, P, and S, T1, and T2 are each independently selected from the group consisting of O, NR, and CH2, where R=H or C1-C8 alkyl, or C1-C8 oxoalkyl, and L is selected from the group consisting of ethylene, propylene, and four to six-membered alicyclic and aromatic rings, provided that structure I does not include AI-2-borate. The compounds may be used to treat bacterial infections in human beings and to regulate biofilm formation. Pharmaceutical compositions comprising one or more such compounds are useful for treating, bacterial infections in human beings.
    Type: Application
    Filed: May 17, 2006
    Publication date: March 8, 2007
    Inventors: Stephen Cooper, Kraig Yager
  • Gyrase inhibitors
    Patent number: 6984652
    Abstract: Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
    Type: Grant
    Filed: May 17, 2004
    Date of Patent: January 10, 2006
    Assignee: Warner-Lambert Company LLC
    Inventors: Kraig Yager, Shaosong Chu, Krzysztof Appelt, Xiaoming Li
  • Gyrase inhibitors
    Publication number: 20050250823
    Abstract: Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
    Type: Application
    Filed: July 7, 2005
    Publication date: November 10, 2005
    Inventors: Kraig Yager, Shaosong Chu, Krzysztof Appelt, Xiaoming Li
  • Gyrase inhibitors
    Publication number: 20050054697
    Abstract: Compounds comprising an indazolyl group and a thiazolyl group, preferably 7-substituted 3-(thiazol-2-yl)-1H-indazole compounds in which the indazolyl group and a thiazolyl group are each independently optionally substituted, are useful for the treatment or prophylaxis of bacterial infections in mammals. The compounds are believed to function by inhibiting gyrase B.
    Type: Application
    Filed: May 17, 2004
    Publication date: March 10, 2005
    Inventors: Kraig Yager, Shaosong Chu, Krzysztof Appelt, Xiaoming Li
  • Pharmaceutical uses and synthesis of nicotinanilide-N-oxides
    Publication number: 20050026965
    Abstract: Disclosed are nicotinanilide-N-oxide compounds, methods for their production, pharmaceutical compositions which include these compounds, and methods for their use in various therapies.
    Type: Application
    Filed: February 17, 2004
    Publication date: February 3, 2005
    Applicant: Darwin Discovery Limited
    Inventors: Neil Cutshall, Kraig Yager